[PLX] YoY Quarter Result on 31-Dec-2009 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
25-Feb-2010
Financial Year
2009
Quarter
31-Dec-2009 [#Q4]
Profit Trend
QoQ- -153.41%
YoY- -127.13%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
Revenue 48 2,362 1,176 388 0 0 150 -17.28%
PBT 968 968 22,414 31,440 9,390 -2,080 5,717 -25.60%
Tax -1,741 -27,616 -20,470 -16,504 -15,838 -20,800 -118 56.54%
NP -9,877 -8,913 -8,528 -14,936 -6,576 -5,131 -9,301 1.00%
Tax Rate 179.86% 2,852.89% 91.33% 52.49% 168.67% - 2.06% -
Total Cost 9,925 11,275 9,704 15,324 6,576 5,131 9,451 0.81%
Ratio Analysis
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
NP Margin -20,577.08 -377.35 -725.17 -3,849.48 0.00 0.00 -6,200.63 22.10%
Per Share
31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 CAGR
EPS -1.07 -1.01 -1.04 -1.85 -0.87 -0.70 -1.45 -4.93%
EPS Diluted -1.07 -1.01 -1.04 -1.85 -0.87 -0.68 -1.45 -4.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.